Related Experiment Video
Updated: Nov 20, 2025
08:56
Transient Expression in Nicotiana Benthamiana Leaves for Triterpene Production at a Preparative Scale
Published on: August 16, 2018
17.8K
Triterpenoids from Walsura trichostemon.
Alfarius Eko Nugroho1, Yusuke Hirasawa1, Toshio Kaneda1
1Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-ku, Tokyo, 142-8501, Japan.
Journal of Natural Medicines
|January 22, 2021
Summary
Researchers isolated seven new triterpenoids from Walsura trichostemon stems. These compounds demonstrated in vitro inhibitory activity against the A549 human lung adenocarcinoma cell line, suggesting potential anticancer applications.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Walsura trichostemon is a plant species with potential medicinal properties.
- Triterpenoids are a class of natural compounds known for diverse biological activities.
- Lung adenocarcinoma is a major type of non-small cell lung cancer.
Purpose of the Study:
- To isolate and characterize new triterpenoids from Walsura trichostemon.
- To evaluate the in vitro antiproliferative activity of isolated compounds against a human lung adenocarcinoma cell line.
Main Methods:
- Bioactivity-guided fractionation of Walsura trichostemon stem methanolic extract.
- Structure elucidation of isolated compounds using spectroscopic methods.
- In vitro antiproliferative assays using A549 cells.
Main Results:
- Four new dammarane triterpenoids (1-4) and two new apotirucallane triterpenoids (5-6) were isolated.
- One known limonoid (7) and two known triterpenoids were also identified.
- Compounds 1-7 exhibited in vitro inhibitory activity against A549 cell proliferation.
Conclusions:
- Walsura trichostemon is a source of novel bioactive triterpenoids.
- The isolated compounds, particularly 1-7, show potential as leads for lung cancer therapeutics.
- Further investigation into the mechanism of action and in vivo efficacy is warranted.
